Double antiplatelet therapy: current views on the appointment, termination and renewal

The article is devoted to the modern views on the appointment, termination and renewal of double antiplatelet therapy in patients with acute coronary syndrome. Classification and mechanisms of action of antiplatelet drugs, the results of their research and conclusions with an emphasis on the duration of double antiplatelet therapy are presented in the article. The results of own studies have confirmed that double antiplatelet therapy effectively blocks the activity of platelet aggregation both in patients subjected to PCI and in patients after acute myocardial infarction.